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Summary 
Background: Early diagnosis of acute kidney injury (AKI)
after cardiac surgery is based on serum creatinine which is
neither a specific nor a sensitive biomarker. In our study, we
investigated the role of serum Klotho in early prediction of
AKI after cardiac surgery using cardiopulmonary bypass
(CPB).
Methods: The included patients were classified into three
groups according to AKI stages using KDIGO criteria. The
measurements of creatinine and Klotho levels in serum were
performed before surgery, at the end of CPB, 2 hours after
the end of CPB, 24 hours and 48 hours postoperatively.
Results: Seventy-eight patients were included in the study.
A significant increase of creatinine levels (p<0.001) was
measured on the first day after the surgery in both AKI
groups compared to the non-AKI group. However, a signif-
icant difference between AKI-2 and AKI-1 groups
(p=0.006) was not measured until the second day after
the operation. Using decision trees for classification of
patients with a higher or lower risk of AKI we found out that
Klotho discriminated between the patients at low risk of
developing more severe kidney injury in the first hours after
surgery and the patients at high risk better than creatinine.
Adding also the early measurements of creatinine in the
decision tree model further improved the prediction of AKI.
Conclusions: Serum Klotho may be useful to discriminate
between the patients at lower and the patients at higher
Kratak sadr`aj
Uvod: Rana dijagnoza akutnog o{te}enja bubrega (AKI)
posle operacije srca se zasniva na kreatininu u serumu koji
nije ni specifi~an ni osetljiv biomarker. U na{oj studiji,
istra`ivali smo ulogu serumskog Klotho-a u ranom
predvi|anju AKI nakon operacije srca koriste}i kardiopul-
monarni bajpas (CPB).
Metode: Uklju~eni pacijenti su klasifikovani u tri grupe u
skladu sa AKI fazama po KDIGO kriterijumu. Merenje krea-
tinina i Klotho-a u serumu je bilo izvedeno pre operacije,
krajem CPB, dva sata nakon zavr{etka CPB, 24 sati i 48 sati
postoperativno.
Rezultati: U studiju je uklju~eno sedamdeset osam pacije-
nata. Povi{enje nivoa kreatinina prvi dan posle operacije je
bilo zna~ajno (p < 0,001) u obe AKI grupe u pore|enju sa
non-AKI grupom, a zna~ajna razlika izme|u grupa AKI-2 i
AKI-1 (p = 0,006) bila je izmerena tek drugi dan posle
operacije. Upotreba stabla odlu~ivanja za klasifikaciju paci-
jenata sa manjim i sa ve}im rizikom od razvijanja o{te}enja
bubrega pokazala je da je Klotho u prvim satima nakon
operacije bolji od kreatinina u diferencijaciji izme|u pacije-
nata sa manjim i pacijenata sa ve}im rizikom od o{te}enja
bubrega. Predvi|anje razvoja te`eg o{te}enja bubrega bilo
je jo{ bolje sa dodatnim uklju~ivanjem ranih rezultata krea-
tinina u model.
Zaklju~ak: Serumski Klotho mo`e biti koristan za diferenci-
jaciju izme|u pacijenata sa manjim i pacijenata sa ve}im
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Introduction
Acute kidney injury (AKI) that can occur after
the surgery is characterized by rapid progressive com-
plications and adverse outcomes, which are raising
morbidity and mortality rates high above ordinary
rates observed in major surgeries (1–3). Criteria for
classification of AKI stages have evolved over the
years, and recently the Kidney Disease Improving
Global Outcomes (KDIGO) consensus conference on
AKI recommended re-arrangement and harmoniza-
tion of classification criteria for AKI by using new
KDIGO criteria (4). Although classifications and defi-
nitions of AKI are well established, they are insuffi-
cient for early diagnosis of AKI as they mainly rely on
serum creatinine which is neither a specific nor a sen-
sitive marker; its baseline is affected by sex, age,
dietary status, muscle mass, medications and it is
raised eventually when 50% of kidney function is
already lost (5). Early prediction and prognosis of AKI
are inevitable to improve the treatment. Therefore,
novel markers are needed, which would be used side
by side with common traditional biomarkers like crea-
tinine. The role of cystatin C, neutrophil gelatinase-
associated lipocalin, kidney injury molecule 1, inter-
leukin-18 and other novel early markers of AKI has
been evaluated in several studies (6, 7) but for some
potential early markers like Klotho, the data are still
very limited.
Klotho is originally produced as a single pass
transmembrane protein with a small extracellular
domain. After the removal of the extracellular domain
by secretases, two types of Klotho with different func-
tions are released (8, 9). While membrane-bound
Klotho acts as a receptor for fibroblast growth factor-
23, secreted soluble Klotho regulates several ion
channels (10, 11), growth factors like IGF-1 and is
also involved in oxidative stress (12). Klotho is expres -
sed in high concentration in renal tubules, but it can
also be found in the brain and to a lower extent also
in the parathyroid gland and the heart (13–15). 
The pathophysiological mechanism by which
Klotho is involved in kidney injury is still puzzling. The
potential role of Klotho in AKI was proposed by Hu et
al. (16). The model assumed that exposure to acute
ischemia, oxidative stress and some other factors is a
potential reason for the decrease of Klotho levels.
Lower Klotho levels may be an aggravating factor of
renal damage. If renal damage is mild, the kidney tis-
sue will recover, while in the case of more severe
injuries, regeneration could stop and subsequent
fibrosis could than even worsen renal Klotho insuffi-
ciency. Several protective actions of Klotho were pro-
posed including reduction of oxidative stress through
regulation of expression of mitochondrial superoxide
dismutase and catalase (17) and prevention of apop-
tosis through activation of heat shock protein-70
(18).
Recent studies of AKI on rodent models
revealed an initial reduction of renal, blood and uri-
nary Klotho levels in response to renal tubular injury
with a possibility of reversing after the regeneration of
kidney function (19, 20), indicating an association of
AKI with a state of endogenous Klotho deficiency. In
human studies, the decrease of renal Klotho expres-
sion in AKI was found to be associated with the sever-
ity of the kidney injury (21).  
In our study, we aimed to assess the significance
of serum Klotho for early diagnosis of AKI after car-
diac surgery using cardiopulmonary bypass (CPB). 
Materials and Methods
Subjects 
The present pilot study was conducted on
patients who were admitted to Department of
Cardiovascular Surgery at the University Medical
Center Ljubljana for elective cardiac surgery with CPB
and was a part of a larger study of kidney function.
Preoperative kidney function was normal in all studied
patients. The exclusion criteria were a history of kid-
ney disease including diabetic nephropathy, renal
transplantation, malignancy, autoimmune diseases
and pregnancy. Based on the experience from the
previous work (22), the included patients were classi-
fied into three groups according to AKI stages instead
of simple classification into AKI and non-AKI groups.
The classification was done based on KDIGO criteria
(4) using the concentration of creatinine in serum at
different time-points. The study was carried out
according to the declaration of Helsinki. The National
Medical Ethics Committee of the Republic of Slovenia
approved the study protocol, and informed consent
was obtained from all study participants before data
collection.
Methods 
Blood samples were collected before surgery, at
the end of CPB, 2h after the end of CPB, 24h and
48h postoperatively. Samples were collected in tubes
without additives; following centrifugation aliquots of
risk of developing severe kidney injury after cardiac surgery
using CPB already in the first hours after surgery. 
Keywords: acute kidney injury, cardiac surgery, vreati-
nine, klotho protein
rizikom od razvijanja te`eg o{te}enja bubrega posle
operacije srca koriste}i CPB ve} u prvim satima nakon
operacije.
Klju~ne re~i: akutno o{te}enje bubrega, operacija srca,
kreatinin, Klotho
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serum were frozen and stored at -20 °C until analysis.
The measurement of Klotho levels in serum was per-
formed by ELISA kit (Elabscience Ltd, Wuhan, China)
with detection limit 0.19 mg/L and CV < 10% while
the concentration of serum creatinine was measured
using automatic kinetic Jaffe reaction (Siemens Healt -
hcare Diagnostics Inc., Newark, DE, USA), which is
traceable to IDMS reference method. Estimated glo -
merular filtration rates for all patients were calculated
using the MDRD equation (23).
Statistical analysis 
Data were expressed as mean ± standard devi-
ation. The time-series collection of blood samples
were analyzed by using the repeated measures
ANOVA test with the post-hoc analysis made by Bon -
ferroni’s correction procedure. Significance was set at
p < 0.05. Decision trees including early measure-
ments of Klotho, creatinine or the combination of
both parameters as independent variables were used
for early classification of patients into two groups:
patients at higher risk of AKI and patients at a lower
risk. Areas under the ROC curve were calculated for
these classifications. Statistical analyses were per-
formed with the SPSS software (IBM SPSS Statistics,
version 20).
Results 
Seventy-eight patients were included in the
study; they were classified into three groups accord-
ing to AKI stages. The classification was based on
changes in serum creatinine using KDIGO criteria as
shown in Table I. Creatinine levels are shown in
Figure 1. The preoperative concentrations of serum
Klotho were not significantly different between the
groups. During the surgery Klotho levels decreased in
all groups, reaching the minimum of approximately
half of the preoperative values at the end of CPB. Two
hours after CPB, its levels increased above the preop-
erative baseline and ultimately decreased back within
48 hours as shown in Figure 2 and Table II. Although
at the end of CPB there was a great difference in
Klotho levels between the groups (p = 0.086), the
differences were not significant at any time-point. The
levels were not significantly different between the
groups before surgery. A great increase (p < 0.001)
was measured 24 hours after the surgery in AKI-2
and AKI-1 groups compared to the non-AKI group,
Figure 1 The estimated marginal means of serum creati-
nine. Legend: 1: preoperative; 2: at the end of CPB; 3: 2
hours after the end of CPB; 4: 24 hours postoperatively; 5:
48 hours postoperatively. Error bars correspond to standard





























Table I A summary of clinical characteristics of patients in all three groups: non-AKI, AKI-1 and AKI-2. 
Non-AKI AKI-1 AKI-2
Number of patients and Gender (m/f) 26 (13/13) 30 (15/15) 22 (12/10)
Age (yrs) 68.3 ± 11.1 71.8 ± 12.7 74.0 ± 7.7
Preoperative eGFR (mL/min/1.73 m2) 102.7 ± 26.2 119.9 ± 59.9 113.8 ± 47.9
Preoperative Creatinine (mmol/L) 67.0 ± 15.7 77.2 ± 44.1 75.3 ± 33.0
Diabetes mellitus (none/oral/insulin) 17/6/3 21/5/4 15/5/2
Arterial hypertension (y/n) 6/20 5/25 5/17
Cardiopulmonary bypass time (min) 93.6 ± 32.4 95.5 ± 36.8 106.7 ± 36.7
Aortic cross-clamping (min) 72.3 ± 30.4 71.2 ± 30.9 81.5 ± 29.9
RBC transfusion (units) 1.8 ± 2.3 2.6 ± 3.6 2.2 ± 1.8
Fresh frozen plasma (mL/kg) 1.3 ± 1.8 2.2 ± 3.3 1.0 ± 1.4
Intensive care unit stay (days) 5.0 ± 5.0 8.9 ± 9.6 6.5 ± 4.6
Hospital stay (days) 11.3 ± 7.3 17.7±23.6 11.8±7.0
but the increase in AKI-2 group became significantly
higher than in AKI-1 group (p = 0.006) no earlier
than 48 hours after surgery.
To discriminate between patients at low risk of
developing severe kidney injury after surgery and the
patients at high risk, decision trees were used.
Patients were classified into the group at higher risk of
AKI (AKI-2) and the group at lower risk (non-AKI +
AKI-1). Decision trees were made using only Klotho
or only creatinine concentrations and also using the
combination of both markers. Figure 3 shows the
decision tree, which was built using Klotho and crea-
tinine concentrations at the end of the surgery, two
hours after the end of surgery and also the differ-
ences from the preoperative concentration. At the
beginning, in the Node 0, we started with a group of
22 patients classified as AKI-2 according to KDIGO
criteria. The optimal division at the first level was
achieved by selecting the parameter delta Klotho con-
centration at the end of CPB at value 35.685. In the
first and second subgroup 23.6 % and 16.7 % of
patients were classified as AKI-2, respectively. The
second division was made in the first group, where
the optimal threshold was estimated based on the
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Figure 2 The estimated marginal means of serum Klotho
concentrations. Legend: 1: preoperative; 2: at the end of
CPB; 3: 2 hours after the end of CPB; 4: 24 hours postop-
eratively; 5: 48 hours postoperatively. Error bars correspond
to standard errors of estimated marginal means in the

















Table II The estimated marginal means and standard errors of serum creatinine and Klotho concentrations at different time-
points. 
Table III Classification of patients using decision trees includ-
ing Klotho and creatinine concentrations at the end of the
surgery, two hours after the end and also the differences from
the preoperative concentration. 
Non-AKI AKI-1 AKI-2
Serum creatinine (mmol/L)
Preoperative 67.0 ± 15.7 77.2 ± 44.1 75.3 ± 33.0
At the end of CPB 64.6 ± 16.3 80.6 ± 33.5 83.3 ± 22.7
2 hours after the end of CPB 72.0 ± 13.0 90.7 ± 39.6 91.5 ± 26.5
24 hours postoperatively 70.6 ± 19.5 106.6 ± 54.1 131.7 ± 41.7
48 hours postoperatively 65.8 ± 20.6 112.8 ± 63.0 162.1 ± 70.7
Serum Klotho (mg/L)
Preoperative 1.75 ± 1.03 1.80 ± 0.73 1.85 ± 1.30
At the end of CPB 0.70 ± 0.72 0.80 ± 0.76 1.21 ± 0.95
2 hours after the end of CPB 1.83 ± 0.95 2.16 ± 1.38 2.26 ± 1.15
24 hours postoperatively 1.60 ± 0.92 1.67 ± 0.71 1.83 ± 0.89








Non-AKI + AKI-1 51 5 91.1 %
AKI-2 10 12 54.5 %
Overall percentage 78.2 % 21.8 % 80.8 %
Creatinine
Non-AKI + AKI-1 40 16 71.4 %
AKI-2 4 18 81.8 %
Overall percentage 56.4 % 43.6 % 74.4 %
Klotho + creatinine
Non-AKI + AKI-1 45 11 80.4 %
AKI-2 2 20 90.9 %
Overall percentage 60.3 % 39.7 % 83.3 %
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parameter delta Creatinine concentration at the end
of CPB at value 31.995. The last division in this deci-
sion tree was made with the optimally chosen param-
eter of Creatinine concentration before the operation. 
The summary results for all three decision trees
are presented in Table III. The input parameters in the
first decision tree were Klotho concentrations at the
end of the surgery, two hours after the end of surgery
and the differences from the preoperative concentra-
tion. The outputs of the classification were probabili-
ties of the patient to belong to AKI-2 or non-
AKI+AKI-1 group. In this case, we achieved the
overall accuracy of 80.8 %. The input parameters in
the second decision tree were creatinine concentra-
tions at the end of the surgery, two hours after the
end of surgery and also the differences from the pre-
operative concentration. The classification results
were produced in the same way as in the Klotho case.
The overall accuracy of 74.4 % was achieved. The
best overall accuracy (83.3 %) was achieved in the
case of the decision tree where the input parameters
were both Klotho and creatinine concentrations at the
end of the surgery, two hours after the end of surgery
and also the differences from the preoperative con-
centrations. Areas under the ROC curve for Klotho,
creatinine and the combination of both parameters
were 0.84, 0.82 and 0.92, respectively (Figure 4).
Discussion
AKI following cardiac surgery can be reversible,
but in worse cases, it can progress into irreversible
stages. In our study, we evaluated serum levels of
Klotho as a possible early marker of AKI after cardiac
surgery using CBP. Immediately after the surgery,
Klotho levels were drastically decreased in all groups
of patients indicating the influence of the surgical
procedure on the kidney. To evaluate the significance
of serum Klotho as a marker of AKI in the first hours
after surgery, we used decision trees for classification
of patients with a higher and lower risk of AKI. Klotho
discriminated between the patients at low risk of
developing severe kidney injury after the surgery and
the patients at high risk better than creatinine.
Combination of both parameters in the decision tree
model further improved the early prediction of AKI.
Serum creatinine exhibited a significant differ-
ence between groups on the first day after the opera-
tion, but the levels were not significantly higher in
AKI-2 group than in AKI-1 group until the second day
after the operation. Since the classification of patients
to the groups was based on creatinine changes, the
observed differences between the groups on the sec-
ond day after surgery were expected. 
Figure 4 Areas under the ROC curve for Klotho, creatinine
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Figure 3 Classification of patients using decision tree,
which includes the concentrations of Klotho and creatinine
in serum. Group 0: non-AKI + AKI-1; group 1: AKI-2.
AKI vs non AKI
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The decrease of Klotho after the operation
could be partially caused by the effect of CPB used
during the surgery, which can lead to volume deple-
tion, decreased renal blood flow and renal ischemic
injury (24, 25). Liu YJ et al. (26) found out that
Klotho levels in serum samples of patients who devel-
oped AKI after cardiac valve replacement were signif-
icantly reduced immediately after the surgery and
restituted four hours to three days postoperatively
while no decrease was measured in samples of
patients who did not develop AKI. Studies on animal
models also found a remarkable decrease in plasma
and urinary Klotho within three hours after the renal
insult (27). Our measurements two hours after the
end of CPB showed that Klotho levels increased
above the preoperative levels in all groups. These ini-
tial changes were followed by a continuous decrease
of serum Klotho levels on the first and the second
postoperative day, indicating only a transient stimulus
for increased Klotho production. Considering the pro-
tective role of Klotho, which was described by several
researchers in AKI (20, 27) as well as in chronic kid-
ney disease (28, 29), the fast increase after the initial
stimulus might be explained as a saving response to
prevent further inflammation, apoptosis and attenua-
tion of renal injury. This is adding some new perspec-
tive to the possible use of Klotho: it might prove to be
not only an early marker of AKI but also a therapeutic
agent (19).
To our knowledge, there is only one study
describing the role of serum Klotho as a marker of
AKI after cardiac surgery. The researchers found a
significant difference in serum Klotho values between
the non-AKI group and AKI group in the first hours
after surgery (26), but they did not divide AKI patients
to subgroups according to AKI stages. Therefore, it is
not possible to directly compare the two studies.
Nevertheless, the conclusion that serum Klotho may
be useful for early discrimination between the patients
at low risk of developing severe kidney injury after sur-
gery and the patients at high risk (AKI stage 2) is sup-
ported by the results of both studies.
When investigating the role of Klotho in kidney
injury, some researchers focused on Klotho levels in
human urine and renal tissue. The decrease of Klotho
values in renal tissue and urine samples after acute
kidney injury was confirmed in animal studies (19)
and association of urinary Klotho with nephron func-
tion in chronic kidney disease was also reported in
human studies (29). The role of urinary Klotho as a
marker of AKI after the surgical procedure has not yet
been confirmed in human studies, and some authors
suggested that urinary Klotho is not a good candidate
for AKI marker (30). In contrast to urinary Klotho, his-
tological examinations revealed the correlation of
renal Klotho expression and the severity of AKI
regardless of the etiology (21) suggesting the poten-
tial of Klotho as a marker of AKI severity.
Although the results of this pilot study show the
potential role of Klotho in early prediction of AKI after
cardiac surgery using CPB, we should be aware of
several limitations, especially when using the decision
trees. In this study, the same population of patients
was used to set the model and to calculate the results.
Future studies are needed to independently validate
the proposed statistical approach. It is also worth
mentioning that at the present moment, Klotho is still
under research and therefore the reference ranges of
serum and urine levels are not clearly defined. As the
methods for the measurement of Klotho levels are not
easily comparable, the use of any cut-offs for decision
making would be limited.
Conclusion 
Using the decision trees models, serum Klotho
may be useful to identify patients at low risk of devel-
oping more severe kidney injury after cardiac surgery
using CPB and separate them from patients at high
risk already in the first hours after surgery.
Adding also the results of early measurements
of creatinine to decision trees models could further
improve the prediction of AKI.
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